Novo Nordisk ousts boss as Ozempic maker battles slump

Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Novo Nordisk has ousted chief executive Lars Fruergaard Jørgensen, as the maker of pioneering obesity drug Ozempic battles a slump…







